#231
PDF
IF 5.70
Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review
Bibliographic Details
- Authors
- Corresponding Author(s) +
- Kelsen, S. G.
- Journal / Publisher
- Resp. Res
- Publication Date
- 2025
- Volume / Edition
- 26
- Pages
- 302
- Impact Factor
- 5.70
Citation
Kelsen, S. G., Maurer, M., Waters, M., Dash, A., Fong, A., Mohan, D., Theess, W., Yang, X., Alvaro, G., Brightling, C. E.: Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Resp. Res 2025: 26; 302. IF: 5.70